Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption
Open Access
- 27 February 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Mechanisms underlying durable control of HIV after antiretroviral therapy interruption remain poorly understood. Here we provide a comprehensive longitudinal analysis in a non-human primate model of post-treatment control using SIVmac251-infected male cynomolgus macaques (pVISCONTI study). Controllers exhibit lower levels of SIV DNA, intact proviruses, transcriptional activity, and viral evolution compared to non-controllers in blood and tissues long after therapy interruption. Before interruption, controllers already have fewer intact proviruses in lymph nodes, and this difference persists in blood shortly after interruption, prior to viral rebound. Intact provirus levels in lymph nodes before interruption negatively correlate with CD8⁺ T-cell capacity to suppress SIV and reflect rebound magnitude. The study demonstrates that markers of post-treatment control are detectable in lymph nodes before therapy interruption and in blood shortly after, and suggests that host immune responses may shape intact provirus profiles during treatment.Keywords
Funding Information
- MSD avenir; ANRS MIE
This publication has 74 references indexed in Scilit:
- Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCell Reports, 2023
- Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variantsCell Host & Microbe, 2023
- Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyCell Host & Microbe, 2023
- An ordeal that does not heal: understanding barriers to a cure for HIV-1 infectionTrends in Immunology, 2022
- Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC StudyCell Reports, 2020
- HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse ReservoirsCell Host & Microbe, 2019
- The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 InfectionsCell Host & Microbe, 2019
- Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated ParticipantsCell Reports, 2017
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013
- Do most lymphocytes in humans really reside in the gut?Trends in Immunology, 2007